Superales, Donna Lyn .
HRN: 21-75-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/28/2022
08/04/2022
IV
160 Mg
Q6
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes